Newborn Screening Market - Global Industry Analysis

Newborn Screening Market by Product (Instruments and Assay Kits and Reagents), by Screening Test (Dry Blood Spot Test, Critical Congenital Heart Disease, Hearing Screen, Urine Test, and Other Tests), and by End-User (Hospitals, Clinics, and Diagnostic Centers): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Published Date: 09-Jul-2019 Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-3223 Status : Published

Global newborn screening market expected to generate around USD 1,584 million by 2025, at a CAGR of around 11.5% between 2019 and 2025. The growing base of neonatal population, increasing cases of congenital diseases, favorable government policies, and technological advancements are likely to aid the global newborn screening market growth.

Description

The report covers a forecast and an analysis of the newborn screening market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes the drivers and restraints of the newborn screening market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the newborn screening market on a global level.

In order to give the users of this report a comprehensive view of the newborn screening market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.

The study provides a decisive view of the newborn screening market by segmenting it based on the product, screening test, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Some leading players operating in the global newborn screening market are Bio-Rad Laboratories, GE Healthcare, Thermo Fisher Scientific, Agilent Technologies, ZenTech, Trivitron Healthcare, PerkinElmer, Natus Medical, MP Biomedicals, and Medtronic.

This report segments the global newborn screening market into:

Global Newborn Screening Market: By Product

  • Instruments
    • Pulse Oximeter
    • Mass Spectrometer
    • Hearing Screening Devices
    • Laparoscopes
    • Retinoscopes
    • Ultrasound Machines
    • Others
  • Assay Kits and Reagents

Global Newborn Screening Market: By Screening Test

  • Dry Blood Spot Test
  • Critical Congenital Heart Disease (CCHD)
  • Hearing Screen
  • Urine Test
  • Other Tests

Global Newborn Screening Market: By end-user

  • Hospitals
  • Clinics
  • Diagnostic Centers

Global Newborn Screening Market: By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global newborn screening market, 2016-2025 (USD Million)
    • 2.2. Global newborn screening market: Snapshot
  •  
  • Chapter 3. New Born Screening Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Global newborn screening market drivers: impact analysis
      • 3.2.2. Growing newborn screening programs
      • 3.2.3. Rising congenital diseases incidences
      • 3.2.4. Rising government funding for newborn screening
      • 3.2.5. Advancements in technologies used in newborn screening
    • 3.3. Market Restraints
      • 3.3.1. Global newborn screening market restraints: impact analysis
      • 3.3.2. Lack of uniformity of newborn screening policies and procedures globally
      • 3.3.3. False positive and false negative results
    • 3.4. Opportunities
      • 3.4.1. Partnerships of private investors with hospitals and diagnostic centers
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis, by product
      • 3.6.2. Market attractiveness analysis, by screening test
      • 3.6.3. Market attractiveness analysis, by end-user
      • 3.6.4. Market attractiveness analysis, by region
  •  
  • Chapter 4. Global Newborn Screening Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global newborn screening market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New therapy launch
      • 4.2.3. Agreements, partnerships, collaborations, and joint ventures
      • 4.2.4. Research and development and regional expansion
    • 4.3. Price trend analysis
  •  
  • Chapter 5. Global Newborn Screening Market - Product Analysis
    • 5.1. Global newborn screening market: product overview
      • 5.1.1. Global newborn screening market revenue share, by product, 2018 and 2025
    • 5.2. Instruments
      • 5.2.1. Global newborn screening market by instruments, 2016-2025 (USD Million)
    • 5.3. Assay Kits and Reagents
      • 5.3.1. Global newborn screening market by assay kits and reagents, 2016-2025 (USD Million)
  •  
  • Chapter 6. Global Newborn Screening Market - Screening Test Analysis
    • 6.1. Global newborn screening market: screening test overview
      • 6.1.1. Global newborn screening market revenue share, by screening test, 2018 and 2025
    • 6.2. Dry Blood Spot Tests
      • 6.2.1. Global newborn screening market for dry blood spot tests, 2016-2025 (USD Million)
    • 6.3. Critical Congenital Heart Disease (CCHD)
      • 6.3.1. Global newborn screening market for critical congenital heart disease (CCHD), 2016-2025 (USD Million)
    • 6.4. Hearing Screen
      • 6.4.1. Global newborn screening market for hearing screen, 2016-2025 (USD Million)
    • 6.5. Urine Test
      • 6.5.1. Global newborn screening market for urine test, 2016-2025 (USD Million)
    • 6.6. Other Tests
      • 6.6.1. Global newborn screening market for other tests, 2016-2025 (USD Million)
  •  
  • Chapter 7. Global Newborn Screening Market - End-User Analysis
    • 7.1. Global newborn screening market: end-user overview
      • 7.1.1. Global newborn screening market revenue share, by end-user, 2018 and 2025
    • 7.2. Hospitals
      • 7.2.1. Global newborn screening market for hospitals, 2016-2025 (USD Million)
    • 7.3. Clinics
      • 7.3.1. Global newborn screening market for ambulatory surgical centers, 2016-2025 (USD Million)
    • 7.4. Diagnostic Centers
      • 7.4.1. Global newborn screening market for diagnostic centers, 2016-2025 (USD Million)
  •  
  • Chapter 8. Global Newborn Screening Market - Regional Analysis
    • 8.1. Global newborn screening market: regional overview
      • 8.1.1. Global newborn screening market revenue share, by region, 2018 and 2025
    • 8.2. North America
      • 8.2.1. North America newborn screening market revenue, by product, 2016-2025 (USD Million)
      • 8.2.2. North America newborn screening market revenue, by screening test, 2016-2025 (USD Million)
      • 8.2.3. North America newborn screening market revenue, by end-user, 2016-2025 (USD Million)
      • 8.2.4. The U.S.
        • 8.2.4.1. The U.S. newborn screening market revenue, by product, 2016-2025 (USD Million)
        • 8.2.4.2. The U.S. newborn screening market revenue, by screening test, 2016-2025 (USD Million)
        • 8.2.4.3. The U.S. newborn screening market revenue, by end-user, 2016-2025 (USD Million)
      • 8.2.5. Canada
        • 8.2.5.1. Canada newborn screening market revenue, by product, 2016-2025 (USD Million)
        • 8.2.5.2. Canada newborn screening market revenue, by screening test, 2016-2025 (USD Million)
        • 8.2.5.3. Canada newborn screening market revenue, by end-user, 2016-2025 (USD Million)
    • 8.3. Europe
      • 8.3.1. Europe newborn screening market revenue, by product, 2016-2025 (USD Million)
      • 8.3.2. Europe newborn screening market revenue, by screening test, 2016-2025 (USD Million)
      • 8.3.3. Europe newborn screening market revenue, by end-user, 2016-2025 (USD Million)
      • 8.3.4. UK
        • 8.3.4.1. UK newborn screening market revenue, by product, 2016-2025 (USD Million)
        • 8.3.4.2. UK newborn screening market revenue, by screening test, 2016-2025 (USD Million)
        • 8.3.4.3. UK newborn screening market revenue, by end-user, 2016-2025 (USD Million)
      • 8.3.5. Germany
        • 8.3.5.1. Germany newborn screening market revenue, by product, 2016-2025 (USD Million)
        • 8.3.5.2. Germany newborn screening market revenue, by screening test, 2016-2025 (USD Million)
        • 8.3.5.3. Germany newborn screening market revenue, by end-user, 2016-2025 (USD Million)
      • 8.3.6. France
        • 8.3.6.1. France newborn screening market revenue, by product, 2016-2025 (USD Million)
        • 8.3.6.2. France newborn screening market revenue, by screening test, 2016-2025 (USD Million)
        • 8.3.6.3. France newborn screening market revenue, by end-user, 2016-2025 (USD Million)
      • 8.3.7. Rest of Europe
        • 8.3.7.1. Rest of Europe newborn screening market revenue, by product, 2016-2025 (USD Million)
        • 8.3.7.2. Rest of Europe newborn screening market revenue, by screening test, 2016-2025 (USD Million)
        • 8.3.7.3. Rest of Europe newborn screening market revenue, by end-user, 2016-2025 (USD Million)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific newborn screening market revenue, by product, 2016-2025 (USD Million)
      • 8.4.2. Asia Pacific newborn screening market revenue, by screening test, 2016-2025 (USD Million)
      • 8.4.3. Asia Pacific newborn screening market revenue, by end-user, 2016-2025 (USD Million)
      • 8.4.4. China
        • 8.4.4.1. China newborn screening market revenue, by product, 2016-2025 (USD Million)
        • 8.4.4.2. China newborn screening market revenue, by screening test, 2016-2025 (USD Million)
        • 8.4.4.3. China newborn screening market revenue, by end-user, 2016-2025 (USD Million)
      • 8.4.5. Japan
        • 8.4.5.1. Japan newborn screening market revenue, by product, 2016-2025 (USD Million)
        • 8.4.5.2. Japan newborn screening market revenue, by screening test, 2016-2025 (USD Million)
        • 8.4.5.3. Japan newborn screening market revenue, by end-user, 2016-2025 (USD Million)
      • 8.4.6. India
        • 8.4.6.1. India newborn screening market revenue, by product, 2016-2025 (USD Million)
        • 8.4.6.2. India newborn screening market revenue, by screening test, 2016-2025 (USD Million)
        • 8.4.6.3. India newborn screening market revenue, by end-user, 2016-2025 (USD Million)
      • 8.4.7. Rest of Asia Pacific
        • 8.4.7.1. Rest of Asia Pacific newborn screening market revenue, by product, 2016-2025 (USD Million)
        • 8.4.7.2. Rest of Asia Pacific newborn screening market revenue, by screening test, 2016-2025 (USD Million)
        • 8.4.7.3. Rest of Asia Pacific newborn screening market revenue, by end-user, 2016-2025 (USD Million)
    • 8.5. Latin America
      • 8.5.1. Latin America newborn screening market revenue, by product, 2016-2025 (USD Million)
      • 8.5.2. Latin America newborn screening market revenue, by screening test, 2016-2025 (USD Million)
      • 8.5.3. Latin America newborn screening market revenue, by end-user, 2016-2025 (USD Million)
      • 8.5.4. Brazil
        • 8.5.4.1. Brazil newborn screening market revenue, by product, 2016-2025 (USD Million)
        • 8.5.4.2. Brazil newborn screening market revenue, by screening test, 2016-2025 (USD Million)
        • 8.5.4.3. Brazil newborn screening market revenue, by end-user, 2016-2025 (USD Million)
      • 8.5.5. Rest of Latin America
        • 8.5.5.1. Rest of Latin America newborn screening market revenue, by product, 2016-2025 (USD Million)
        • 8.5.5.2. Rest of Latin America newborn screening market revenue, by screening test, 2016-2025 (USD Million)
        • 8.5.5.3. Rest of Latin America newborn screening market revenue, by end-user, 2016-2025 (USD Million)
    • 8.6. The Middle East and Africa
      • 8.6.1. The Middle East and Africa newborn screening market revenue, by product, 2016-2025 (USD Million)
      • 8.6.2. The Middle East and Africa newborn screening market revenue, by screening test, 2016-2025 (USD Million)
      • 8.6.3. The Middle East and Africa newborn screening market revenue, by end-user, 2016-2025 (USD Million)
  •  
  • Chapter 9. Company Profile
    • 9.1. Bio-Rad Laboratories
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product portfolio
      • 9.1.4. Business strategy
      • 9.1.5. Recent developments
    • 9.2. GE Healthcare
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Product portfolio
      • 9.2.4. Business strategy
      • 9.2.5. Recent developments
    • 9.3. Thermo Fisher Scientific
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Product portfolio
      • 9.3.4. Business strategy
      • 9.3.5. Recent developments
    • 9.4. Agilent Technologies
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product portfolio
      • 9.4.4. Business strategy
      • 9.4.5. Recent developments
    • 9.5. ZenTech
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product portfolio
      • 9.5.4. Business strategy
      • 9.5.5. Recent developments
    • 9.6. Trivitron Healthcare
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product portfolio
      • 9.6.4. Business strategy
      • 9.6.5. Recent developments
    • 9.7. PerkinElmer
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Product portfolio
      • 9.7.4. Business strategy
      • 9.7.5. Recent developments
    • 9.8. Natus Medical Incorporated
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Product portfolio
      • 9.8.4. Business strategy
      • 9.8.5. Recent developments
    • 9.9. MP Biomedicals
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Product portfolio
      • 9.9.4. Business strategy
      • 9.9.5. Recent developments
    • 9.10. Medtronic
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Product portfolio
      • 9.10.4. Business strategy
      • 9.10.5. Recent developments

Table Of Figures

List of Figures

1. Market research process
2. Market methodology
3. Global newborn screening market revenue, 2016–2025 (USD Million)
4. Porter’s Five Forces Analysis
5. Newborn screening market attractiveness analysis, by product
6. Newborn screening market attractiveness analysis, by screening test
7. Newborn screening market attractiveness analysis, by end-user
8. Newborn screening market attractiveness analysis, by region
9. Company market share analysis, 2018
10. Global newborn screening market revenue share by product, 2018 and 2025
11. Global newborn screening market for instruments,2016–2025 (USD Million)
12. Global newborn screening market for assay kits and reagents, 2016–2025 (USD Million)
13. Global newborn screening market revenue share by screening test, 2018 and 2025
14. Global newborn screening market for dry blood spot tests, 2016–2025 (USD Million)
15. Global newborn screening market for critical congenital heart disease (CCHD),2016–2025 (USD Million)
16. Global newborn screening market for hearing screen, 2016–2025 (USD Million)
17. Global newborn screening market for urine screen, 2016–2025 (USD Million)
18. Global newborn screening market for other tests, 2016–2025 (USD Million)
19. Global newborn screening market revenue share by end-user, 2018 and 2025
20. Global newborn screening market for hospitals, 2016–2025 (USD Million)
21. Global newborn screening market for clinics, 2016–2025 (USD Million)
22. Global newborn screening market for diagnostic centers, 2016–2025 (USD Million)
23. Global newborn screening market revenue share by region, 2018 and 2025
24. North America newborn screening market, 2016–2025 (USD Million)
25. Europe newborn screening market, 2016–2025 (USD Million)
26. Asia Pacific newborn screening market, 2016–2025 (USD Million)
27. Latin America newborn screening market, 2016–2025 (USD Million)
28. The Middle East and Africa newborn screening market, 2016–2025 (USD Million)


Table Of Tables

List of Tables

1. Newborn screening market: Market Snapshot
2. Drivers of the global newborn screening market: impact analysis 
3. Restraints of the global newborn screening market: impact analysis
4. North America newborn screening market revenue, by product, 2016–2025 (USD Million)
5. North America newborn screening market revenue, by screening test, 2016–2025 (USD Million)
6. North America newborn screening market revenue, by end-user, 2016–2025 (USD Million)
7. The U.S. newborn screening market revenue, by product, 2016–2025 (USD Million)
8. The U.S. newborn screening market revenue, by screening test, 2016–2025 (USD Million)
9. The U.S. newborn screening market revenue, by end-user, 2016–2025 (USD Million)
10. Canada newborn screening market revenue, by product, 2016–2025 (USD Million)
11. Canada newborn screening market revenue, by screening test, 2016–2025 (USD Million)
12. Canada newborn screening market revenue, by end-user, 2016–2025 (USD Million)
13. Europe newborn screening market revenue, by product, 2016–2025 (USD Million)
14. Europe newborn screening market revenue, by screening test, 2016–2025 (USD Million)
15. Europe newborn screening market revenue, by end-user, 2016–2025 (USD Million)
16. U.K. newborn screening market revenue, by product, 2016–2025 (USD Million)
17. U.K. newborn screening market revenue, by screening test, 2016–2025 (USD Million)
18. U.K. newborn screening market revenue, by end-user, 2016–2025 (USD Million)
19. Germany newborn screening market revenue, by product, 2016–2025 (USD Million)
20. Germany newborn screening market revenue, by screening test, 2016–2025 (USD Million)
21. Germany newborn screening market revenue, by end-user, 2016–2025 (USD Million)
22. France newborn screening market revenue, by product, 2016–2025 (USD Million)
23. France newborn screening market revenue, by screening test, 2016–2025 (USD Million)
24. France newborn screening market revenue, by end-user, 2016–2025 (USD Million)
25. Rest of Europe newborn screening market revenue, by product, 2016–2025 (USD Million)
26. Rest of Europe newborn screening market revenue, by screening test, 2016–2025 (USD Million)
27. Rest of Europe newborn screening market revenue, by end-user, 2016–2025 (USD Million)
28. Asia Pacific newborn screening market revenue, by product, 2016–2025 (USD Million)
29. Asia Pacific newborn screening market revenue, by screening test, 2016–2025 (USD Million)
30. Asia Pacific newborn screening market revenue, by end-user, 2016–2025 (USD Million)
31. China newborn screening market revenue, by product, 2016–2025 (USD Million)
32. China newborn screening market revenue, by screening test, 2016–2025 (USD Million)
33. China newborn screening market revenue, by end-user, 2016–2025 (USD Million)
34. Japan newborn screening market revenue, by product, 2016–2025 (USD Million)
35. Japan newborn screening market revenue, by screening test, 2016–2025 (USD Million)
36. Japan newborn screening market revenue, by end-user, 2016–2025 (USD Million)
37. India newborn screening market revenue, by product, 2016–2025 (USD Million)
38. India newborn screening market revenue, by screening test, 2016–2025 (USD Million)
39. India newborn screening market revenue, by end-user, 2016–2025 (USD Million)
40. Rest of Asia Pacific newborn screening market revenue, by product, 2016–2025 (USD Million)
41. Rest of Asia Pacific newborn screening market revenue, by screening test, 2016–2025 (USD Million)
42. Rest of Asia Pacific newborn screening market revenue, by end-user, 2016–2025 (USD Million)
43. Latin America newborn screening market revenue, by product, 2016–2025 (USD Million)
44. Latin America newborn screening market revenue, by screening test, 2016–2025 (USD Million)
45. Latin America newborn screening market revenue, by end-user, 2016–2025 (USD Million)
46. Brazil newborn screening market revenue, by product, 2016–2025 (USD Million)
47. Brazil newborn screening market revenue, by screening test, 2016–2025 (USD Million)
48. Brazil newborn screening market revenue, by end-user, 2016–2025 (USD Million)
49. Rest of Latin America newborn screening market revenue, by product, 2016–2025 (USD Million)
50. Rest of Latin America newborn screening market revenue, by screening test, 2016–2025 (USD Million)
51. Rest of Latin America newborn screening market revenue, by end-user, 2016–2025 (USD Million)
52. The Middle East and Africa newborn screening market revenue, by product, 2016–2025 (USD Million)
53. The Middle East and Africa newborn screening market revenue, by screening test, 2016–2025 (USD Million)
54. The Middle East and Africa newborn screening market revenue, by end-user, 2016–2025 (USD Million)

Methodology

Free Analysis

Newborn screening is a preventive pediatric screening test usually performed to diagnose any inborn abnormalities or congenital metabolism defects. Normally, newborns are more susceptible to infections, which can arise at any time, even from the first day of their lives. These newborn screening tests help physicians in the early detection of serious genetic disorders, which can result in a lifetime of disability if not treated at the right time. Newborn screening helps physicians to start the treatment from the initial stage, once the disease is diagnosed to reverse its prognosis. Early diagnosis and treatment help in the subsequent reduction of associated disabilities. These newborn programs differ from country to country, depending on the prevalence rate of different diseases and legal requirements for screening tests.

The global newborn screening market is mainly driven by the growing incidences of neonatal diseases, which is leading to the high demand for newborn screening tests. Initiatives by the government in creating awareness about neonatal hereditary diseases are further boosting the newborn screening market growth globally. Technological advancements and growth in funding from government organizations are also propelling this market. Additionally, companies are also engaging in partnerships and collaborations to extend their product offerings, to increase their market shares and expand operations. These partnerships and collaborations are helping enhance the R&D capabilities for manufacturing innovative devices to meet different consumer needs. In 2015, for instance, Roche Diagnostics and Human Longevity entered into a collaboration of Roche Diagnostics' subsidiary Genentech's to conduct whole-genome sequencing on de-identified samples. The partnership helped Roche Diagnostics to discover new diagnostics and targeted therapies and analyze patient samples based on precise genetic categories. These collaborative activities are also fast-tracking drug discovery efforts, which can help detect chromosomal abnormalities in neonates and in the development of new therapies, thus further boosting the newborn screening market globally.

By product, the market for newborn screening is divided into instruments and assay kits and reagents. The instruments segment is further classified into pulse oximeter, mass spectrometer, hearing screening devices, laparoscopes, retinoscopes, ultrasound machines, and others. On the basis of screening test, the newborn screening market is fragmented into critical congenital heart disease, dry blood spot test, hearing screen, urine test, and other tests. Based on end-user, the newborn screening market is divided into hospitals, clinics, and diagnostic centers.

North America dominated the global newborn screening market in 2018, due to enforced testing and increasing prevalence of congenital disorders in 50 regional states. Newborn screening program and tests are thoroughly followed in all the North American states. As per the CDC, in 2014, around four million babies annually are screened for various congenital conditions. Conditions for screening were provided through extensive research by the American College of Medical Genetics (ACMG). The Asia Pacific newborn screening market is likely to show the highest growth rate in the future, due to the presence of promising healthcare schemes enlisted by government agencies.

Some leading players operating in the global newborn screening market are Bio-Rad Laboratories, GE Healthcare, Thermo Fisher Scientific, Agilent Technologies, ZenTech, Trivitron Healthcare, PerkinElmer, Natus Medical, MP Biomedicals, and Medtronic.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed